These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. -509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection. Qi P, Chen YM, Wang H, Fang M, Ji Q, Zhao YP, Sun XJ, Liu Y, Gao CF. Cancer Immunol Immunother; 2009 Sep; 58(9):1433-40. PubMed ID: 19169878 [Abstract] [Full Text] [Related]
23. Association of the GLB1 rs4678680 genetic variant with risk of HBV-related hepatocellular carcinoma. Wang WT, Li Z, Shi M, Zhu H, Xiong X, Shang J, Liu J, Teng M, Yang M. Oncotarget; 2016 Aug 30; 7(35):56501-56507. PubMed ID: 27489354 [Abstract] [Full Text] [Related]
24. IL-17 and IL-21 polymorphisms in relation to HBV related hepatocellular carcinoma in Chinese Han population. Wu W, Zeng Y, Lin J, Chen T, Xun Z, Li B, Wang C, Qin X, Qiu Y, Li Y, Chen M, Liang H, Li L, Shang H, Liu C, Ou Q. Infect Genet Evol; 2021 Jan 30; 87():104638. PubMed ID: 33232805 [Abstract] [Full Text] [Related]
28. Association of PvuII and XbaI polymorphisms in estrogen receptor alpha gene with the risk of hepatitis B virus infection in the Guangxi Zhuang population. Liu Y, Liu Y, Huang X, Sui J, Mo C, Wang J, Peng Q, Deng Y, Huang L, Li S, Qin X. Infect Genet Evol; 2014 Oct 30; 27():69-76. PubMed ID: 25014269 [Abstract] [Full Text] [Related]
29. Genetic variant in visfatin gene promoter contributes to reduced risk of hepatocellular carcinoma in a Chinese population. Wu Z, Sun Y, Huang Y, Zhu S, Feng Y, Ye H, Liu C, Tang S. Oncotarget; 2016 Nov 22; 7(47):77968-77977. PubMed ID: 27792999 [Abstract] [Full Text] [Related]
33. Association of polymorphism rs1053005 in STAT3 with chronic hepatitis B virus infection in Han Chinese population. Li M, Li F, Li N, Sang J, Fan X, Deng H, Zhang X, Han Q, Lv Y, Liu Z. BMC Med Genet; 2018 Apr 02; 19(1):52. PubMed ID: 29609539 [Abstract] [Full Text] [Related]
34. CDC25B is associated with the risk of hepatocellular carcinoma, but not related to persistent infection of hepatitis B virus in a Chinese population. Wang P, Peng J, Gong Y, Shen N. Mol Biol Rep; 2020 May 02; 47(5):3361-3368. PubMed ID: 32248384 [Abstract] [Full Text] [Related]
35. Gene polymorphisms of interleukin 28B and the risk to chronic hepatitis B virus infection in Thai. Kimkong I, Chankaew J, Kunanopparat A, Hirankarn N, Tangkijvanich P. Tissue Antigens; 2015 Mar 02; 85(3):177-81. PubMed ID: 25664396 [Abstract] [Full Text] [Related]
36. Genetic polymorphisms in Toll-like receptor 3 gene are associated with the risk of hepatitis B virus-related liver diseases in a Chinese population. Huang X, Li H, Wang J, Huang C, Lu Y, Qin X, Li S. Gene; 2015 Sep 15; 569(2):218-24. PubMed ID: 26024592 [Abstract] [Full Text] [Related]
37. Association study of single nucleotide polymorphisms in XRCC1 gene with risk of hepatocellular carcinoma in Chinese Han population. Bi J, Zhong C, Li K, Chu H, Wang B. Biomed Res Int; 2013 Sep 15; 2013():138785. PubMed ID: 23984316 [Abstract] [Full Text] [Related]
38. Correlation between the DEPDC5 rs1012068 polymorphism and the risk of HBV-related hepatocellular carcinoma. Liu W, Ma N, Zhao D, Gao X, Zhang X, Yang L, Liu D. Clin Res Hepatol Gastroenterol; 2019 Aug 15; 43(4):446-450. PubMed ID: 30683632 [Abstract] [Full Text] [Related]
40. IL-23R polymorphisms, HBV infection, and risk of hepatocellular carcinoma in a high-risk Chinese population. Xu Y, Liu Y, Pan S, Liu L, Liu J, Zhai X, Shen H, Hu Z. J Gastroenterol; 2013 Jan 15; 48(1):125-31. PubMed ID: 22735941 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]